Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples